Crispr Therapeutics: Awaiting Approval And Clarity For Market Prospects Seeking Alpha, 25 Jul 2023 Summary CRISPR Therapeutics, leading in gene-editing technology, progresses with exa-cel for treating beta-thalassemia, severe…